Metastatic Colorectal Cancers Completed Phase 1 / 2 Trials for Conatumumab (DB11646)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00630786Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer StudyTreatment
NCT00625651Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal CancerTreatment